Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diletta Di Mitri

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
International Journal of Molecular Sciences|June 10, 2023
NK Cells in Cancer: Mechanisms of Dysfunction and Therapeutic PotentialFederica Portale, Diletta Di Mitri
Trends in Cell Biology|November 14, 2015
Non-Cell-Autonomous Regulation of Cellular Senescence in CancerDiletta Di Mitri, Andrea Alimonti
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 2015
Molecular Pathways: Targeting Tumor-Infiltrating Myeloid-Derived Suppressor Cells for Cancer TherapyDiletta Di Mitri, Alberto Toso, Andrea Alimonti
The Journal of Experimental Medicine|February 24, 2023
Macrophages and bone metastasisDiletta Di Mitri, Fabio Conforti, Alberto Mantovani
Oncoimmunology|September 26, 2015
Tumor-infiltrating myeloid cells drive senescence evasion and chemoresistance in tumorsDiletta Di Mitri, Alberto Toso, Andrea Alimonti
Cellular & Molecular Immunology|October 14, 2024
Macrophage diversity in cancer dissemination and metastasisAlberto Mantovani, Federica Marchesi, Diletta Di Mitri, et al.
Nature Reviews. Cancer|July 23, 2020
Neutrophil diversity and plasticity in tumour progression and therapySebastien Jaillon, Andrea Ponzetta, Diletta Di Mitri, et al.
Blood|October 23, 2008
CD49d provides access to "untouched" human Foxp3+ Treg free of contaminating effector cellsMarkus Kleinewietfeld, Mireille Starke, Diletta Di Mitri, et al.
Journal for Immunotherapy of Cancer|July 7, 2022
Lipid-loaded macrophages as new therapeutic target in cancerGiulia Marelli, Nicolò Morina, Federica Portale, et al.
Immunology Letters|January 14, 2014
CD28 ligation in the absence of TCR stimulation up-regulates IL-17A and pro-inflammatory cytokines in relapsing-remitting multiple sclerosis T lymphocytesCristina Camperio, Michela Muscolini, Elisabetta Volpe, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
International Journal of Molecular Sciences|June 10, 2023
NK Cells in Cancer: Mechanisms of Dysfunction and Therapeutic PotentialFederica Portale, Diletta Di Mitri
Trends in Cell Biology|November 14, 2015
Non-Cell-Autonomous Regulation of Cellular Senescence in CancerDiletta Di Mitri, Andrea Alimonti
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 2015
Molecular Pathways: Targeting Tumor-Infiltrating Myeloid-Derived Suppressor Cells for Cancer TherapyDiletta Di Mitri, Alberto Toso, Andrea Alimonti
The Journal of Experimental Medicine|February 24, 2023
Macrophages and bone metastasisDiletta Di Mitri, Fabio Conforti, Alberto Mantovani
Oncoimmunology|September 26, 2015
Tumor-infiltrating myeloid cells drive senescence evasion and chemoresistance in tumorsDiletta Di Mitri, Alberto Toso, Andrea Alimonti
Cellular & Molecular Immunology|October 14, 2024
Macrophage diversity in cancer dissemination and metastasisAlberto Mantovani, Federica Marchesi, Diletta Di Mitri, et al.
Nature Reviews. Cancer|July 23, 2020
Neutrophil diversity and plasticity in tumour progression and therapySebastien Jaillon, Andrea Ponzetta, Diletta Di Mitri, et al.
Blood|October 23, 2008
CD49d provides access to "untouched" human Foxp3+ Treg free of contaminating effector cellsMarkus Kleinewietfeld, Mireille Starke, Diletta Di Mitri, et al.
Journal for Immunotherapy of Cancer|July 7, 2022
Lipid-loaded macrophages as new therapeutic target in cancerGiulia Marelli, Nicolò Morina, Federica Portale, et al.
Immunology Letters|January 14, 2014
CD28 ligation in the absence of TCR stimulation up-regulates IL-17A and pro-inflammatory cytokines in relapsing-remitting multiple sclerosis T lymphocytesCristina Camperio, Michela Muscolini, Elisabetta Volpe, et al.
Pageof 4